Citation: Fj. Couch et Lc. Hartmann, BRCA1 TESTING - ADVANCES AND RETREATS, JAMA, the journal of the American Medical Association, 279(12), 1998, pp. 955-957
Authors:
CONOVER CA
HARTMANN LC
BRADLEY S
STALBOERGER P
KLEE GC
KALLI KR
JENKINS RB
Citation: Ca. Conover et al., BIOLOGICAL CHARACTERIZATION OF HUMAN EPITHELIAL OVARIAN-CARCINOMA CELLS IN PRIMARY CULTURE - THE INSULIN-LIKE-GROWTH-FACTOR SYSTEM, Experimental cell research, 238(2), 1998, pp. 439-449
Authors:
BOARDMAN LA
THIBODEAU SN
SCHAID DJ
LINDOR NM
MCDONNELL SK
BURGART LJ
AHLQUIST DA
PODRATZ KC
PITTELKOW M
HARTMANN LC
Citation: La. Boardman et al., INCREASED RISK FOR CANCER IN PATIENTS WITH THE PEUTZ-JEGHERS-SYNDROME, Annals of internal medicine, 128(11), 1998, pp. 896
Authors:
LAWRENCE JB
CONOVER CA
HADDAD TC
INGLE JN
REID JM
AMES MM
SUMAN VJ
MARKS RS
ERLICHMAN C
HARTMANN LC
Citation: Jb. Lawrence et al., EVALUATION OF CONTINUOUS-INFUSION SURAMIN IN METASTATIC BREAST-CANCER- IMPACT ON PLASMA-LEVELS OF INSULIN-LIKE GROWTH-FACTORS (IGFS) AND IGF-BINDING PROTEINS, Clinical cancer research, 3(10), 1997, pp. 1713-1720
Citation: Lc. Hartmann et Vj. Suman, GRANULOCYTE-COLONY-STIMULATING FACTOR IN AFEBRILE PATIENTS WITH NEUTROPENIA - REPLY, The New England journal of medicine, 337(18), 1997, pp. 1319-1320
Authors:
HARTMANN LC
TSCHETTIER LK
HABERMANN TM
EBBERT LP
JOHNSON PS
MAILLIARD JA
LEVITT R
SUMAN VJ
WITZIG TE
WIEAND HS
MILLER LL
MOERTEL CG
Citation: Lc. Hartmann et al., GRANULOCYTE-COLONY-STIMULATING FACTOR IN SEVERE CHEMOTHERAPY-INDUCED AFEBRILE NEUTROPENIA, The New England journal of medicine, 336(25), 1997, pp. 1776-1780
Authors:
INGLE JN
JOHNSON PA
SUMAN VJ
GERSTNER JB
MAILLIARD JA
CAMORIANO JK
GESME DH
LOPRINZI CL
HATFIELD AK
HARTMANN LC
Citation: Jn. Ingle et al., A RANDOMIZED PHASE-II TRIAL OF 2 DOSAGE LEVELS OF LETROZOLE AS 3RD-LINE HORMONAL-THERAPY FOR WOMEN WITH METASTATIC BREAST-CARCINOMA, Cancer, 80(2), 1997, pp. 218-224
Authors:
BOARDMAN LA
SCHROEDER JJ
MCDONNELL SK
BURGART LJ
HARTMANN LC
SCHAID DJ
THIBODEAU SN
Citation: La. Boardman et al., LINKAGE ANALYSIS IN PEUTZ-JEGHERS-SYNDROME TO CHROMOSOMAL ARM 19P, American journal of human genetics, 61(4), 1997, pp. 327-327
Authors:
BOARDMAN LA
THIBODEAU SN
AHLQUIST DA
HARTMANN LC
Citation: La. Boardman et al., THE ASSOCIATION OF PEUTZ-JEGHERS SYNDROME WITH THE DEVELOPMENT OF MALIGNANCY, Gastroenterology, 110(4), 1996, pp. 492-492
Authors:
HABERMANN TM
HARTMANN LC
TSCHETTER LK
WIEAND HS
EBBERT LP
MAILLIARD JA
LEVITT R
WITZIG TE
SUMAN V
Citation: Tm. Habermann et al., RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF G-CSF FOR FEBRILE-NEUTROPENIC PATIENTS, Blood, 88(10), 1996, pp. 1375-1375
Authors:
INGLE JN
KROOK JE
MAILLIARD JA
HARTMANN LC
WIEAND HS
Citation: Jn. Ingle et al., EVALUATION OF IFOSFAMIDE PLUS MESNA AS FIRST-LINE CHEMOTHERAPY IN WOMEN WITH METASTATIC BREAST-CANCER, American journal of clinical oncology, 18(6), 1995, pp. 498-501
Authors:
STORLIE JA
BUCKNER JC
WISEMAN GA
BURCH PA
HARTMANN LC
RICHARDSON RL
Citation: Ja. Storlie et al., PROSTATE-SPECIFIC ANTIGEN LEVELS AND CLINICAL-RESPONSE TO LOW-DOSE DEXAMETHASONE FOR HORMONE-REFRACTORY METASTATIC PROSTATE CARCINOMA, Cancer, 76(1), 1995, pp. 96-100
Authors:
PHILLIPS MR
BOWER TC
ORSZULAK TA
HARTMANN LC
Citation: Mr. Phillips et al., INTRACARDIAC EXTENSION OF AN INTRACAVAL SARCOMA OF ENDOMETRIAL ORIGIN, The Annals of thoracic surgery, 59(3), 1995, pp. 742-744
Authors:
HARTMANN LC
PODRATZ KC
KEENEY GL
KAMEL NA
EDMONSON JH
GRILL JP
SU JQ
KATZMANN JA
ROCHE PC
Citation: Lc. Hartmann et al., PROGNOSTIC-SIGNIFICANCE OF P53 IMMUNOSTAINING IN EPITHELIAL OVARIAN-CANCER, Journal of clinical oncology, 12(1), 1994, pp. 64-69
Authors:
ERICKSON LD
HARTMANN LC
SU JQ
NIELSEN SNJ
PFEIFEL DM
GOLDBERG RM
LEVITT R
STANHOPE CR
Citation: Ld. Erickson et al., CYCLOPHOSPHAMIDE, CISPLATIN, AND LEUPROLIDE ACETATE IN PATIENTS WITH DEBULKED STAGE-III OR STAGE-IV OVARIAN-CARCINOMA, Gynecologic oncology, 54(2), 1994, pp. 196-200
Authors:
PISANSKY TM
HALYARD MY
WEAVER AL
DONOHUE JH
GRADO GL
GRANT CS
HARTMANN LC
INGLE JN
SCHOMBERG PJ
WOLD LE
Citation: Tm. Pisansky et al., BREAST-CONSERVATION THERAPY FOR INVASIVE BREAST-CANCER - A REVIEW OF PRIOR TRIALS AND THE MAYO-CLINIC EXPERIENCE, Mayo Clinic proceedings, 69(6), 1994, pp. 515-524
Authors:
HARTMANN LC
INGLE JN
WOLD LE
FARR GH
GRILL JP
SU JQ
MAIHLE NJ
KROOK JE
WITZIG TE
ROCHE PC
Citation: Lc. Hartmann et al., PROGNOSTIC VALUE OF C-ERBB2 OVEREXPRESSION IN AXILLARY LYMPH-NODE POSITIVE BREAST-CANCER - RESULTS FROM A RANDOMIZED ADJUVANT TREATMENT PROTOCOL, Cancer, 74(11), 1994, pp. 2956-2963
Authors:
INGLE JN
FOLEY LF
MAILLIARD JA
KROOK JE
HARTMANN LC
JUNG SH
VEEDER MH
GESME DH
HATFIELD AK
GOLDBERG RM
Citation: Jn. Ingle et al., RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL WITH OR WITHOUT ESTROGENIC RECRUITMENT IN WOMEN WITH METASTATIC BREAST-CANCER, Cancer, 73(9), 1994, pp. 2337-2343